Article
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery - 1 Mar 2015
Takenaka Tomoyoshi, Takenoyama Mitsuhiro, Yamaguchi Masafumi, Toyozawa Ryo, Inamasu Eiko, Kojo Miyako, Toyokawa Gouji, Yoshida Tsukihisa, Shiraishi Yoshimasa, Morodomi Yosuke, Hirai Fumihiko, Taguchi Kenichi, Shimokawa Mototsugu, Seto Takashi, Ichinose Yukito
Abstract excerpt
OBJECTIVES: The impact of epidermal growth factor receptor (EGFR) status and the use of EGFR-tyrosine kinase inhibitor (EGFR-TKI) therapy have not been well discussed only in recurrent non-small-cell lung cancer (NSCLC). The purpose of this study was to identify the prognostic factors associated with post-recurrence survival after surgical resection of NSCLC in terms of the EGFR mutation status and the use of...
Topics
Join the communities discussing this publication.
